Increased extraosseus 99m-technetium hydroxy diphosphonate uptake in chronic kidney disease patients with secondary hyperparathyroidism. Correlation with hyperphosphatemia

LH Enevoldsen; James Goya Heaf; P Hasbak

Increased extraosseus 99m-technetium hydroxy diphosphonate uptake in chronic kidney disease patients with secondary hyperparathyroidism. Correlation with hyperphosphatemia

LH Enevoldsen, James Goya Heaf, P Hasbak

Nyresygdomme

Originalsprog	Engelsk
Tidsskrift	European Journal of Nuclear Medicine and Molecular Imaging
Vol/bind	37
Udgave nummer	Suppl. 2
Sider (fra-til)	S471
ISSN	1619-7070
Status	Udgivet - 2010

Citationsformater

Increased extraosseus 99m-technetium hydroxy diphosphonate uptake in chronic kidney disease patients with secondary hyperparathyroidism. Correlation with hyperphosphatemia. / Enevoldsen, LH; Heaf, James Goya; Hasbak, P.
I: European Journal of Nuclear Medicine and Molecular Imaging, Bind 37, Nr. Suppl. 2, 2010, s. S471.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

@article{95415d588c614b7ca14c9d224649ab60,

title = "Increased extraosseus 99m-technetium hydroxy diphosphonate uptake in chronic kidney disease patients with secondary hyperparathyroidism. Correlation with hyperphosphatemia",

author = "LH Enevoldsen and Heaf, {James Goya} and P Hasbak",

year = "2010",

language = "English",

volume = "37",

pages = "S471",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "Suppl. 2",

}

TY - ABST

T1 - Increased extraosseus 99m-technetium hydroxy diphosphonate uptake in chronic kidney disease patients with secondary hyperparathyroidism. Correlation with hyperphosphatemia

AU - Enevoldsen, LH

AU - Heaf, James Goya

AU - Hasbak, P

PY - 2010

Y1 - 2010

M3 - Conference abstract in journal

SN - 1619-7070

VL - 37

SP - S471

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - Suppl. 2

ER -